Bookmark and Share

Last Minute:          For more news, click here.

Remember me? 

Rise of
+0.56 (+0.90%) Bristol-Myers Squ - [Ticker: BMY]Chart Bristol-Myers Squ  News Bristol-Myers Squ  Download Historical Prices for Metastock Bristol-Myers Squ and Others  Technical Analysis Bristol-Myers Squ  
Last Trade62.22Last Trade Time2017-11-01 - 19:35:00
Variation+0.56 (+0.90%)Open61.86
Volume3,541,547Average Volume (3m)0
YieldBid / Ask62.21 x 900 - 62.22 x 1,400
Former Close61.6652 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Bristol-Myers Squ -  [Ticker: BMY] chart
Change to Bristol-Myers Squ Interactive Technical Analysis Chart

Last 10 Forum Topics about Bristol-Myers Squ:
No topics about Bristol-Myers Squ [BMY] have been found, but a search on the Forum for more topics related to Bristol-Myers Squ is advised.

 News about Bristol-Myers Squ [BMY]:   (ordered by relevance)
  1. Bristol Myers Squibb Looks Strong In 2022, Century Deal Can Help Establish Cell Therapy Leadership  Seeking Alpha
  2. Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies  Yahoo Finance
  3. Inside Century Therapeutics' potential $3B deal with Bristol Myers Squibb - Philadelphia Business Journal  Philadelphia Business Journal
  4. Century Therapeutics inks deal with BMS on iPSC-derived allogeneic cel  The Pharma Letter
What's Happening With Bristol Myers Squibb Stock?  Forbes Is Bristol Myers Squibb Stock A Better Pick Over This Vaccine Company?  Forbes Bristol-Myers Squibb (NYSE:BMY) Is Paying Out A Larger Dividend Than Last Year  Nasdaq Bristol-Myers Squibb Company's (BMY) CEO Giovanni Caforio Presents at JPMorgan 40th Annual Healthcare Brokers Conference (Transcript)  Seeking Alpha Do These 3 Checks Before Buying Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming Dividend  Nasdaq Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers  FiercePharma Evotec expands neuroscience collaboration with Bristol Myers Squibb to include new targeted protein degradation approach  Evotec Bristol Myers Squibb exec on the company?s growth in Seattle and beating cancer with immune cells  GeekWire The Zacks Analyst Blog Highlights: Salesforce, Intuit, Bristol-Myers Squibb, QUALCOMM and Lockheed Martin  Yahoo Finance 4 Biotech Acquisitions We'd Like to See in 2022  Motley Fool Bristol Myers Squibb - BMY - Stock Price & News  Motley Fool Should You Buy Bristol Myers Squibb Stock At $63?  Forbes Bristol Myers Squibb Stock Remains Undervalued After Positive Data From Clinical Trials  Forbes Bristol Myers Squibb Announces Earnings Call Time Change; Third Quarter 2021 Earnings Call to Occur on October 27, 2021 at 10 a.m. (Eastern Time)  Business Wire Here's Why Bristol Myers Squibb Stock Is Heating Up Today  The Motley Fool Bristol-Myers Squibb: Underperformance Is Temporary  Seeking Alpha Bristol Myers Squibb Announces Dividend  Business Wire Bristol Myers Launching Nine New Drugs After Bulking Up Pipeline  Bloomberg 3 Big FDA Approvals to Watch For in Q1 2022  The Motley Fool Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland  Business Wire Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?  Motley Fool Fitch Affirms Bristol-Myers Squibb's IDR at 'A-'; Withdraws Ratings; Outlook Revised to Stable  Fitch Ratings Bristol-Myers Squibb (BMY) Q1 2021 Earnings Call Transcript  Motley Fool U.S. FTC okays changes to Bristol Meyers Squibb divestiture agreement  Reuters Bristol Myers, Immatics to Collaborate on IMA401 >BMY IMTX  MarketWatch Why Bristol Myers Squibb Is A Top Socially Responsible Dividend Stock  Forbes Here's Why Shares of Bristol Myers Squibb, Eli Lilly, and Pfizer Rocketed Higher This Week  Motley Fool 3 Best Buffett Stocks to Buy for the Long Haul  The Motley Fool Bristol-Myers Squibb (NYSE:BMY) Has Announced That It Will Be Increasing Its Dividend To US$0.54  Simply Wall St Nektar And Bristol Myers Squibb Expecting Bempeg Approval  Seeking Alpha Bristol Myers Squibb: An Undervalued Dividend Stock With Growth Potential  Seeking Alpha Bristol Myers Squibb Awards ?Golden Tickets? to Promising Biotechs for Residencies at LabCentral, Biolabs@NYULangone and MBC BioLabs  Business Wire Bristol Myers Squibb Provides Update on Phase 2 Study of Deucravacitinib in Patients With Moderate to Severe Ulcerative Colitis  Business Wire U.S. FDA extends review of Bristol Myers' heart disease drug  Reuters Bristol Myers to pay up to $1.56 bln to develop, sell Agenus's cancer therapy (May 18)  Reuters Bristol Myers Squibb's Applications for Deucravacitinib for the Treatment of Moderate to Severe Plaque Psoriasis Accepted by U.S. Food and Drug Administration and Validated by European Medicines Agency  Business Wire Bristol Myers Squibb to Take Part in Morgan Stanley 19th Annual Global Healthcare Conference  Business Wire BRISTOL MYERS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company - BMY  Yahoo Finance 3 Reasons To Invest Like Buffett And Buy Bristol Myers  Seeking Alpha Bristol Myers Squibb Has Unique Cash Flow Strength  Seeking Alpha Bristol-Myers Is Said to Have Weighed Offer for Acceleron  Bloomberg Bristol Myers Squibb Stock Can Offer Better Returns Over Eli Lilly  Forbes Bristol-Myers Squibb (BMY) Q4 2020 Earnings Call Transcript  Motley Fool We Wouldn't Be Too Quick To Buy Bristol-Myers Squibb Company (NYSE:BMY) Before It Goes Ex-Dividend  Nasdaq Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know  Nasdaq Bristol Myers Squibb to Present Data Across Robust Cardiovascular Portfolio at American Heart Association Scientific Sessions 2021  Yahoo Finance Can Gilead Beat Bristol Myers Squibb With Its Cancer CAR-T Therapy? | The Motley Fool  The Motley Fool BRISTOL MYERS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company -  Business Wire Bristol Myers Squibb?s Breyanzi (lisocabtagene maraleucel) Significantly Improves Outcomes, Showing Superiority Over 20-Year Standard of Care in Second-Line Relapsed or Refractory Large B-cell Lymphoma Based on TRANSFORM Study Results  Yahoo Finance CLAIMSFILER ALERTS BRISTOL MYERS Investors to Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company - BMY  PRNewswire Is Bristol Myers Squibb (BMY) Stock A Buy or Sell?  Yahoo Finance Bristol-Myers Squibb completes $20M investment in Compugen  Seeking Alpha BRISTOL-MYERS CVR INVESTORS: December 6, 2021 Filing Deadline in Class Action ? Contact Lieff Cabraser  Business Wire Eisai and Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai's MORAb-202 Antibody Drug Conjugate  Business Wire Bristol Myers Squibb Reports First Quarter Financial Results for 2021  Business Wire BRISTOL MYERS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Bristol-Myers Squibb Company - BMY  Yahoo Finance Bristol Myers Squibb: A Classic Buffett Style 'Fat Pitch'  Seeking Alpha Bristol Myers Gets Europe OK for Zeposia in Ulcerative Colitis >BMY  MarketWatch Bristol-Myers to require U.S., Puerto Rico staff to be vaccinated  Reuters Why Bristol Myers Stock Offers More Than Just A 3.44% Dividend Yield  Seeking Alpha Bristol Myers Squibb Provides Update on Status of Contingent Value Rights  Business Wire Bristol Myers Squibb: Out Of The Rut  Seeking Alpha January Buffett Dividend Dogs Show 3 Dandy Dynamutts  Seeking Alpha Bristol-Myers Squibb Company (BMY) Company Profile, News, Rankings | Fortune  Fortune Bristol-Myers Squibb (BMY) Files Mixed Shelf Registration Statement BRISTOL MYERS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers  Yahoo Finance Bristol Myers is sued for refusing COVID-19 vaccine religious exemptions  Reuters Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for September 30, 2021  Nasdaq It had to happen: Ex-Celgene shareholders sue Bristol Myers Squibb for $6.4B in lost CVR cash, claiming 'blatant misconduct'  FiercePharma Bristol-Myers Squibb: Undervalued Dividend Contender, Offering Income, Dividend Growth, And Capital Appreciation  Seeking Alpha FDA OKs Bristol Myers' Orencia in Acute Graft-Vs-Host Disease >BMY  MarketWatch New Bristol Myers immunotherapy combo better than Opdivo alone in melanoma study  Reuters Bristol Myers 24 Hour Deadline Alert: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits against Bristol-Myers Squibb Company - BMY  Yahoo Finance Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term  Yahoo Finance 3 Reasons Warren Buffett Loves Bristol-Myers Squibb  Seeking Alpha Bristol Myers Gains Covid Antibody in Deal With Rockefeller  Bloomberg Bristol-Myers likely to settle lawsuit related to Celgene drug CVR, analyst says  Seeking Alpha Relyea Zuckerberg Hanson LLC Buys Marsh & McLennan Inc, Colgate-Palmolive Co, iShares MSCI ...  Yahoo Finance Here's Why We Think Bristol-Myers Squibb Company's (NYSE:BMY) CEO Compensation Looks Fair for the time being  Simply Wall St Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb  Business Wire The Executive VP & Chief Information Officer of Bristol-Myers Squibb Company (NYSE:BMY), Paul von Autenried, Just Sold 45% Of Their Holding  Simply Wall St Triple Threat  Seeking Alpha US businesses sour on Saudi Arabia in blow to crown prince's growth plans: WSJ  Press TV Post-split bluebird bio plans to launch 3 gene therapies in 2 years - Boston Business Journal  Boston Business Journal Bristol-Myers Squibb Contingent Value Rights: Thinking Through The Options Around Litigation Financing  Seeking Alpha Pre-Market Most Active for Jan 10, 2022 : ZNGA, SQQQ, TLRY, QQQ, RIO, TQQQ, F, AAPL, PLTR, PHG, BMY, NIO  Nasdaq 3 Reasons Why Bristol Myers (BMY) Is a Great Growth Stock  Yahoo Finance Is Bristol Myers Stock A Buy Or A Sell As Its Recent Downtrend Continues?  Investor's Business Daily ABBV: AbbVie vs. Bristol Myers Squibb: Which Pharmaceutical Stock is a Better Buy? European Shares Rebound Ahead Of Powell Comments  Nasdaq Aurinia Pharmaceuticals drops amid silence on M&A after conference presentations  Seeking Alpha Bristol Myers posts $10 billion loss as it books charges relating to MyoKardia and Celgene  MarketWatch Bristol Myers Squibb CEO Caforio collected $20M in 2020 pay amid Celgene integration, pandemic challenges  FiercePharma The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to Be Trained  Yahoo Finance Bristol Myers Provides Long-Term Guidance: Stock Could Be Poised To Breakout  Seeking Alpha Bristol Myers Squibb Data at EULAR 2021 Highlight Commitment to Driving Advancements Across Multiple Immune-Mediated Rheumatic Diseases  Business Wire How Bristol Myers Squibb's Celgene Buyout Continued to Pay Off in Q4  The Motley Fool Here's Why Bristol Myers Squibb's Partners Think 2021 Could Be Prosperous  Motley Fool Bristol-Myers Squibb Contingent Value Rights: Final Inspection Is Happening  Seeking Alpha
For more news about Bristol-Myers Squ click here:
Bristol-Myers Squ News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources